NOTCH-1 receptors act as novel targets for the development of NAFLD/NASH, where overexpression of NOTCH-1 receptor alters the lipid metabolism in hepatocytes leading to NAFLD. This evidence concerns the gene NOTCH1 and metabolic dysfunction-associated steatohepatitis.